CellSignals


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

CellSignals applies its technology in chiral synthesis to develop lipid mediators pertinent to intracellular signal transduction and cancer biology. Currently CellSignals' product line has grown to more than 40 chemicals covering a variety of inositol polyphosphates and phosphatidylinositol polyphosphates. CellSignals is actively developing small-molecules, orally bio-available therapeutics for the treatments of breast, skin cancers, and leukemia.

CellSignals applies its technology in chiral synthesis to develop lipid mediators pertinent to intracellular signal transduction and cancer biology. Currently CellSignals' product line has grown to more than 40 chemicals covering a variety of inosito...Show all

Company (Alive / Active)

Phone: 614-340-1845

Fax:

1275 Kinnear Rd
Columbus, 43212
Ohio, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CellSignals $0M Nov 17, 2018
U3 Pharma Ag $55.2M May 21, 2008
Chiral Technologies $0M Nov 17, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CellSignals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)